STAT

STAT+: Skylark Bio kicks off new gene therapy trial for deafness

STAT+: Skylark Bio kicks off new gene therapy trial for deafnessWorldPing

Biotech startups in the U.S., France, and China are racing to bring new gene therapies for deafness by targeting different genetic mutations.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

Related news